Dojolvi (Triheptanoin)

Dojolvi (triheptanoin) is approved as a source of calories and fatty acids for children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). In these rare genetic conditions the body cannot break down long-chain fats for energy, leading to low blood sugar, muscle breakdown (rhabdomyolysis) and heart problems.

Triheptanoin is made of three seven-carbon fatty acids that can be broken down without the missing long-chain enzymes. It provides energy and also replenishes key intermediates of the energy cycle in cells. The dose is up to 35 percent of the patient’s total daily calories, divided into at least four doses and mixed with food.

• Gastrointestinal side effects such as abdominal pain, diarrhoea, vomiting and nausea are common; doses are increased gradually to improve tolerance.
• If given through a feeding tube, use only tubes made of compatible materials (silicone or polyurethane), as triheptanoin can degrade some plastics.
• Patients with pancreatic insufficiency may absorb it poorly.
• Dosing must be supervised by a physician experienced in metabolic disorders and should not be combined with another medium-chain triglyceride product.

Is Dojolvi sold in India?

Dojolvi is an imported medicine and is not readily available through regular pharmacies in India. It can still be accessed legally on a named-patient basis, subject to Indian import regulations.

Which papers do I need to send?

Because Dojolvi is brought in for a specific patient, the following are required before we can place the order:

• A valid prescription from a registered metabolic specialist
• Molecular (genetic) report confirming a long-chain fatty acid oxidation disorder
• Patient ID proof issued by the Government of India

How does confirmation work?

Once the prescription has been verified, we confirm the order and share the expected timeline.

Need Dojolvi? Our team works with licensed distributors abroad to bring it in for individual patients and institutions, following Indian import rules.

Price and delivery details: +91-9310090915 | info@indianpharmanetwork.in

Global Approval Status:

• United States: FDA-approved in June 2020.

What is Dojolvi (Triheptanoin) prescribed for?

Dojolvi is a medium-chain triglyceride indicated for long-chain fatty acid oxidation disorders (LC-FAOD).

Who markets Dojolvi?

Dojolvi comes from Ultragenyx Pharmaceutical.

Is Dojolvi a food or a medicine?

It is a prescription medicine, although it is taken mixed with food or drinks as part of a supervised diet.

How does Dojolvi help?

Triheptanoin is made of three seven-carbon fatty acids that can be broken down without the missing long-chain enzymes.

Has Dojolvi been approved by the FDA?

Yes. Dojolvi is FDA-approved as a source of calories and fatty acids for paediatric and adult patients with molecularly confirmed LC-FAOD.